Vitalux Tablet
FDA Label NDC 59088-139

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Puretek Corporation for the product Vitalux (NDC 59088-139). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding full prescribing information, indications and usage:, contraindications:, warning:, precautions:, drug interactions:, adverse reactions:, overdose:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warning:

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

* Please review the disclaimer below.